ArticleClinical pharmacology and therapeutics2022

Semimechanistic Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B-Cell Lymphomas.

Tommy Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.